Strategies for the Discovery of Antivirals Against Respiratory RNA Viruses 2026

Dear Colleagues,

Respiratory RNA viruses continue to pose significant threats to global public health, as evidenced by recent outbreaks and pandemics. This Special Issue aims to highlight innovative strategies and recent advances in the discovery and development of antiviral agents targeting respiratory RNA viruses. Topics of interest include, but are not limited to, structure-based drug design, high-throughput screening, repurposing of existing drugs, and the application of nanotechnology in antiviral development, including the design of nanomaterials for direct virion inhibition, targeted drug delivery, and as novel antiviral platforms. We also welcome contributions on novel therapeutic platforms and the evaluation of antiviral efficacy in preclinical and clinical settings. We invite original research articles, reviews, and perspectives that contribute to the understanding and advancement of antiviral discovery against pathogens such as influenza, RSV, SARS-CoV-2, and other emerging respiratory RNA viruses.

Dr. Yuanwei Pan
Dr. Badri Parshad
Dr. Xinyi Liu
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.